Omeros Corporation Revenue and Competitors

Seattle, WA USA

Location

$965.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Omeros Corporation's estimated annual revenue is currently $47.9M per year.(i)
  • Omeros Corporation received $210.0M in venture funding in November 2018.
  • Omeros Corporation's estimated revenue per employee is $203,809
  • Omeros Corporation's total funding is $965.4M.

Employee Data

  • Omeros Corporation has 235 Employees.(i)
  • Omeros Corporation grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M6200%N/AN/A
#2
$1.1M7-36%N/AN/A
#3
$4.8M3119%N/AN/A
#4
$1.3M17-23%N/AN/A
#5
$31.6M1633%$30.2MN/A
#6
$1.9M120%N/AN/A
#7
$4.2M27-16%N/AN/A
#8
$2.5M16-27%N/AN/A
#9
$0.9M60%N/AN/A
#10
$2.8M180%N/AN/A
Add Company

Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.

keywords:Biotechnology,E-Commerce,Healthcare,Human Resources Hr,Marketing,Pharmaceuticals

$965.4M

Total Funding

235

Number of Employees

$47.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Omeros Corporation News

2022-04-17 - 2022-04-20 | NDAQ:OMER | Press Release | Omeros ...

Omeros Announces Journal of Clinical Oncology Publication Detailing Pivotal ... Omeros Corporation (Nasdaq: OMER) today announced the online...

2022-04-17 - Omeros Announces Journal of Clinical Oncology Publication ...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced the online publication of a manuscript detailing the results of...

2022-04-13 - Omeros Corporation (OMER) Stock: Do Analysts Think You Should Accumulate?

Analysts who follow Omeros Corporation (OMER) on average expect it to add 195.58% over the next twelve months. Those same analysts give the...

2019-09-08 - Omeros Corporation (OMER) Momentum to a Halt as Shares Drop -2.15% For The Week

Omeros Corporation (OMER) have moved lower over the course of the past week revealing negative downward near-term momentum for the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$82.1M2353%$41.4M
#2
$65.9M23612%N/A
#3
$71.7M2366%N/A
#4
$46.9M237N/AN/A
#5
$75.6M237-14%N/A

Omeros Corporation Funding

DateAmountRoundLead InvestorsReference
2006-09-08$UndisclosedUndisclosedARCH Venture Partners, Aravis VentureArticle
2007-01-12$9.0MUndisclosedArticle
2007-02-13$63.0MEMultipleArticle
2008-09-25$20.0MUndisclosedBlueCrest Capital FinanceArticle
2010-07-30$40.0MUndisclosedReedland Capital PartnersArticle
2010-10-26$20.0MUndisclosedVulcan CapitalArticle
2012-06-27$34.5MUndisclosedCowen and Company LLC , Deutsche Bank Securities IncArticle
2013-05-10$16.2MUndisclosedRA Capital ManagementArticle
2014-03-06$32.0MUndisclosedArticle
2014-03-17$35.0MUndisclosedCowen and Company, LLCArticle
2014-03-20$40.2MUndisclosedCowen and Company, LLCArticle
2015-01-29$UndisclosedUndisclosedCowen and Company, LLCArticle
2015-02-05$79.1MUndisclosedCowen and Company, LLCArticle
2016-01-07$70.0MUndisclosedOxford FinanceArticle
2016-05-18$20.0MUndisclosedOxford Finance LLCArticle
2016-08-12$40.0MUndisclosedCantor Fitzgerald & CoArticle
2016-10-28$125.0MUndisclosedCRG LPArticle
2017-08-23$78.5MUndisclosedCantor Fitzgerald & CoArticle
2018-11-09$210.0MUndisclosedCantor Fitzgerald & CoArticle